Shionogi Wants to Pick Global Partner for Oral COVID-19 Drug by Year-End: President

Shionogi President Isao Teshirogi Shionogi President Isao Teshirogi said on November 1 that the company hopes to decide on a partner for the global rollout of its investigational oral COVID-19 drug S-217622 by the end of the year. Speaking at...read more